Poster Presentations at AACR 2026
At AACR 2026, scientists from our WuXi Biology platform will present a collection of the company’s latest oncology research findings through 13 selected posters, focusing on key areas including integrated technology platforms for oncology drug discovery, development of innovative therapies, and elucidation of resistance mechanisms.
WuXi Biology will share its explorations and discoveries in cancer research and engage with global peers to advance scientific progress and clinical translation in oncology. Explore this brief overview of WuXi Biology’s contributions to be featured at AACR 2026.
Related Content
Unlike conventional protein-targeted therapies, which often provide only transient effects, nucleic acid therapeutics have the potential for long-lasting effects and...
VIEW RESOURCETargeted protein degradation (TPD) approaches, including molecular glue degraders (MGDs) and proteolysis targeting chimeras (PROTACs), can overcome traditional occupancy-based inhibitor...
VIEW RESOURCE